Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 9, 2022
- Accession no.
- 0001209191-22-017739
- Filed
- Mar 9, 2022
- Trade date
- Mar 7-9, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $4.66M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +95,926 | $18.35 | +$1,760,242.1 | 334,153 | Indirect | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +7,079 | $18.91 | +$133,863.89 | 341,232 | Indirect | |
| Mar 8, 2022 | Common Stock | PPurchaseAcquired | +42,882 | $18.23 | +$781,738.86 | 384,114 | Indirect | |
| Mar 8, 2022 | Common Stock | PPurchaseAcquired | +42,011 | $19.36 | +$813,332.96 | 426,125 | Indirect | |
| Mar 8, 2022 | Common Stock | PPurchaseAcquired | +18,940 | $19.90 | +$376,906 | 445,065 | Indirect | |
| Mar 9, 2022 | Common Stock | PPurchaseAcquired | +39,600 | $20.07 | +$794,772 | 484,665 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.